Thursday November 26 2009 | Biotechnology feed | All feeds
|
|
Frost & Sullivanhttp://www.frost.com Frost & Sullivan Market Intelligence, New York NY, United States of America.
Frost & Sullivan Recognizes Neotropix's Approach to the Treatment of Small Cell Lung Cancer and Neuroendocrine CancersTuesday 13th of January 2009 7:45BioPortfolio no longer holds the full text of this article, it is however likley to be available via the below links:
![]() Browse other news from this organisation: Frost & Sullivan Related Web-Links(If any, Generated Automatically)![]()
Source PR Newswire |
|